Consistently, LSD1 silencing resulted in significant suppression of proliferation of lung cancer cell lines [96]; moreover, SCLC was sensitive to a LSD1 inhibitor GSK-2879552 [98]. This evidence concerns the gene KDM1A and lung carcinoma.